Advanced search
Publication Cover
Bioengineered Bugs Volume 1, 2010 - Issue 2
Journal homepage
1,077
Views
9
CrossRef citations to date
0
Altmetric
Report

Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice

Jochen Stritzker Genelux Corporation, 3030 Bunker Hill Street, San Diego, CA-92109, USA; Department for Biochemistry, Biocenter, and Institute for Molecular Infection Biology, University Würzburg, Würzburg, Germany
,
Philip J. Hill University of Nottingham, School of Biosciences, Sutton Bonington Campus, UK
,
Ivaylo Gentsche
&
Aladar A. SzalayCorrespondence[email protected]
Pages 139-145 | Received 23 Sep 2009, Accepted 09 Oct 2009, Published online: 01 Mar 2010

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Rui Zhao, Zimai Li, Yuqing Sun, Wei Ge, Mingyu Wang, Huaiwei Liu, Luying Xun & Yongzhen Xia. (2022) Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment. Gut Microbes 14:1.
Read now
Trudy M. Wassenaar. (2018) E. coli and colorectal cancer: a complex relationship that deserves a critical mindset. Critical Reviews in Microbiology 44:5, pages 619-632.
Read now

Articles from other publishers (7)

Lin Yu, Zhen Liu, Wei Xu, Kai Jin, Jinliang Liu, Xiaohui Zhu, Yong Zhang & Yihan Wu. (2023) Towards overcoming obstacles of type II photodynamic therapy: Endogenous production of light, photosensitizer, and oxygen. Acta Pharmaceutica Sinica B.
Crossref
Jason P. Lynch, Lisa Goers & Cammie F. Lesser. (2022) Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics. Trends in Pharmacological Sciences 43:9, pages 772-786.
Crossref
Ting Yin, Zhenying Diao, Nicholas Thomas Blum, Long Qiu, Aiqing Ma & Peng Huang. (2021) Engineering Bacteria and Bionic Bacterial Derivatives with Nanoparticles for Cancer Therapy. Small 18:12.
Crossref
Yensi Flores Bueso, Panos Lehouritis & Mark Tangney. (2018) In situ biomolecule production by bacteria; a synthetic biology approach to medicine. Journal of Controlled Release 275, pages 217-228.
Crossref
Panos Lehouritis, Michael Stanton, Florence O. McCarthy, Matthieu Jeavons & Mark Tangney. (2016) Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria. Journal of Controlled Release 222, pages 9-17.
Crossref
Adrienne W. Paton, Renato Morona & James C. Paton. (2012) Bioengineered microbes in disease therapy. Trends in Molecular Medicine 18:7, pages 417-425.
Crossref
Christoph A. Jacobi & Peter Malfertheiner. (2011) <i>Escherichia coli</i> Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium. Digestive Diseases 29:6, pages 600-607.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.